KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Income towards Parent Company: 2009-2024

Historic Income towards Parent Company for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to -$119.0 million.

  • Nektar Therapeutics' Income towards Parent Company rose 5.58% to -$35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.4 million, marking a year-over-year increase of 32.63%. This contributed to the annual value of -$119.0 million for FY2024, which is 56.90% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Income towards Parent Company of -$119.0 million as of FY2024, which was up 56.90% from -$276.1 million recorded in FY2023.
  • Over the past 5 years, Nektar Therapeutics' Income towards Parent Company peaked at -$119.0 million during FY2024, and registered a low of -$525.1 million during FY2021.
  • Over the past 3 years, Nektar Therapeutics' median Income towards Parent Company value was -$276.1 million (recorded in 2023), while the average stood at -$256.7 million.
  • In the last 5 years, Nektar Therapeutics' Income towards Parent Company declined by 18.15% in 2021 and then surged by 56.90% in 2024.
  • Over the past 5 years, Nektar Therapeutics' Income towards Parent Company (Yearly) stood at -$444.4 million in 2020, then dropped by 18.15% to -$525.1 million in 2021, then increased by 28.56% to -$375.1 million in 2022, then increased by 26.41% to -$276.1 million in 2023, then soared by 56.90% to -$119.0 million in 2024.